Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 16 | 2013 | 267 | 1.410 |
Why?
|
| Surgery, Plastic | 2 | 2025 | 109 | 0.810 |
Why?
|
| Cleft Palate | 2 | 2023 | 221 | 0.710 |
Why?
|
| Hysterectomy, Vaginal | 3 | 2013 | 19 | 0.640 |
Why?
|
| Craniosynostoses | 1 | 2021 | 146 | 0.600 |
Why?
|
| Fertility | 6 | 2011 | 260 | 0.590 |
Why?
|
| Cleft Lip | 1 | 2021 | 195 | 0.550 |
Why?
|
| Gynecologic Surgical Procedures | 9 | 2011 | 66 | 0.550 |
Why?
|
| Endometrial Neoplasms | 3 | 2014 | 108 | 0.510 |
Why?
|
| Ovarian Neoplasms | 4 | 2010 | 421 | 0.490 |
Why?
|
| Sentinel Lymph Node Biopsy | 5 | 2011 | 70 | 0.490 |
Why?
|
| Telemedicine | 1 | 2022 | 525 | 0.450 |
Why?
|
| Hysterectomy | 3 | 2014 | 201 | 0.430 |
Why?
|
| Mucin-5B | 1 | 2013 | 14 | 0.410 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 93 | 0.390 |
Why?
|
| Lymph Nodes | 4 | 2009 | 356 | 0.370 |
Why?
|
| Laparotomy | 1 | 2012 | 138 | 0.350 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 193 | 0.340 |
Why?
|
| Genital Neoplasms, Female | 1 | 2009 | 43 | 0.290 |
Why?
|
| Laparoscopy | 7 | 2011 | 535 | 0.280 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 462 | 0.270 |
Why?
|
| Lung | 1 | 2013 | 1532 | 0.230 |
Why?
|
| Efficiency, Organizational | 1 | 2025 | 55 | 0.230 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2006 | 60 | 0.230 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2005 | 1 | 0.230 |
Why?
|
| CA-125 Antigen | 4 | 2010 | 14 | 0.220 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2005 | 37 | 0.220 |
Why?
|
| Physician Assistants | 1 | 2025 | 81 | 0.210 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 2023 | 22 | 0.200 |
Why?
|
| Aging | 1 | 2010 | 1238 | 0.190 |
Why?
|
| Neoplasm Staging | 10 | 2013 | 1278 | 0.190 |
Why?
|
| Orthopedics | 1 | 2023 | 77 | 0.190 |
Why?
|
| Postoperative Complications | 2 | 2023 | 3115 | 0.190 |
Why?
|
| Spinal Fusion | 1 | 2023 | 125 | 0.180 |
Why?
|
| Humans | 34 | 2025 | 130204 | 0.180 |
Why?
|
| Scoliosis | 1 | 2023 | 147 | 0.180 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 105 | 0.170 |
Why?
|
| Mammaplasty | 1 | 2021 | 44 | 0.170 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2011 | 387 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2021 | 331 | 0.160 |
Why?
|
| Female | 28 | 2023 | 70342 | 0.160 |
Why?
|
| Cicatrix | 1 | 2021 | 124 | 0.160 |
Why?
|
| Job Syndrome | 1 | 2020 | 17 | 0.160 |
Why?
|
| Postoperative Care | 1 | 2021 | 294 | 0.150 |
Why?
|
| Surgeons | 1 | 2023 | 289 | 0.150 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 5166 | 0.140 |
Why?
|
| Lymphatic Metastasis | 5 | 2011 | 425 | 0.130 |
Why?
|
| Pregnancy | 3 | 2011 | 7456 | 0.130 |
Why?
|
| Frozen Sections | 2 | 2009 | 27 | 0.130 |
Why?
|
| Lymph Node Excision | 4 | 2005 | 158 | 0.130 |
Why?
|
| Treatment Outcome | 9 | 2023 | 12824 | 0.120 |
Why?
|
| Child | 5 | 2025 | 26194 | 0.120 |
Why?
|
| Pediatrics | 1 | 2025 | 1243 | 0.120 |
Why?
|
| Vagina | 3 | 2009 | 207 | 0.120 |
Why?
|
| Abdominal Fat | 1 | 2014 | 22 | 0.100 |
Why?
|
| Retrospective Studies | 7 | 2023 | 17577 | 0.100 |
Why?
|
| Mucin 5AC | 1 | 2013 | 23 | 0.100 |
Why?
|
| Ear, Middle | 1 | 2013 | 24 | 0.100 |
Why?
|
| Cilia | 1 | 2013 | 73 | 0.100 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2012 | 9 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2013 | 190 | 0.090 |
Why?
|
| Fertility Preservation | 1 | 2013 | 61 | 0.090 |
Why?
|
| Adult | 12 | 2021 | 31035 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 225 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2013 | 327 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 3 | 2011 | 399 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2013 | 747 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2013 | 1481 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 477 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2011 | 618 | 0.080 |
Why?
|
| Macrophages | 1 | 2013 | 660 | 0.080 |
Why?
|
| Infant | 2 | 2021 | 13298 | 0.070 |
Why?
|
| Vaginal Neoplasms | 1 | 2009 | 17 | 0.070 |
Why?
|
| Patient Selection | 1 | 2012 | 724 | 0.070 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2009 | 25 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 968 | 0.070 |
Why?
|
| Disease Management | 1 | 2012 | 554 | 0.070 |
Why?
|
| Models, Biological | 1 | 2013 | 1375 | 0.070 |
Why?
|
| Research Design | 1 | 2012 | 712 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2331 | 0.070 |
Why?
|
| Carcinoma | 1 | 2010 | 283 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 6764 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 645 | 0.060 |
Why?
|
| Conization | 1 | 2006 | 5 | 0.060 |
Why?
|
| Inflammation | 1 | 2013 | 1479 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2891 | 0.060 |
Why?
|
| Survival Rate | 1 | 2010 | 2105 | 0.060 |
Why?
|
| Abdomen | 1 | 2006 | 125 | 0.060 |
Why?
|
| Efficiency | 1 | 2025 | 74 | 0.060 |
Why?
|
| Asthma | 1 | 2013 | 920 | 0.060 |
Why?
|
| Aged | 5 | 2014 | 20818 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2005 | 176 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 4694 | 0.050 |
Why?
|
| Adolescent | 4 | 2023 | 20816 | 0.050 |
Why?
|
| Vulvar Neoplasms | 1 | 2004 | 18 | 0.050 |
Why?
|
| Quality of Life | 2 | 2021 | 2068 | 0.050 |
Why?
|
| Middle Aged | 6 | 2011 | 28315 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2011 | 1263 | 0.050 |
Why?
|
| Thecoma | 1 | 2002 | 3 | 0.050 |
Why?
|
| Mucin-1 | 1 | 2002 | 32 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6166 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2003 | 81 | 0.050 |
Why?
|
| Ascites | 1 | 2002 | 99 | 0.050 |
Why?
|
| Endometriosis | 1 | 2005 | 161 | 0.050 |
Why?
|
| Palate, Soft | 1 | 2021 | 20 | 0.040 |
Why?
|
| Prognosis | 2 | 2013 | 4847 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 264 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 1119 | 0.040 |
Why?
|
| Malocclusion, Angle Class III | 1 | 2020 | 5 | 0.040 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2020 | 22 | 0.040 |
Why?
|
| Maxilla | 1 | 2020 | 40 | 0.040 |
Why?
|
| Mandible | 1 | 2020 | 96 | 0.040 |
Why?
|
| Male | 3 | 2023 | 64425 | 0.030 |
Why?
|
| Mice | 1 | 2013 | 18173 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 1799 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 902 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2013 | 6407 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 3742 | 0.030 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2014 | 21 | 0.030 |
Why?
|
| Radionuclide Imaging | 2 | 2004 | 113 | 0.030 |
Why?
|
| Debridement | 1 | 2014 | 91 | 0.020 |
Why?
|
| Necrosis | 1 | 2014 | 193 | 0.020 |
Why?
|
| Hematoma | 1 | 2014 | 85 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2013 | 55 | 0.020 |
Why?
|
| Animals | 1 | 2013 | 33676 | 0.020 |
Why?
|
| Young Adult | 3 | 2013 | 10000 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 272 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 4036 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2011 | 155 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11959 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1439 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2010 | 357 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 15015 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2076 | 0.010 |
Why?
|
| Risk Factors | 2 | 2013 | 10967 | 0.010 |
Why?
|
| Rosaniline Dyes | 1 | 2004 | 5 | 0.010 |
Why?
|
| Technetium Compounds | 1 | 2003 | 1 | 0.010 |
Why?
|
| Organotechnetium Compounds | 1 | 2003 | 11 | 0.010 |
Why?
|
| Pelvic Exenteration | 1 | 2003 | 1 | 0.010 |
Why?
|
| Antimony | 1 | 2003 | 14 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2003 | 24 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2004 | 153 | 0.010 |
Why?
|
| Menopause | 1 | 2003 | 85 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2003 | 155 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 1578 | 0.010 |
Why?
|
| Research | 1 | 2003 | 264 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 631 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 740 | 0.010 |
Why?
|
| Drainage | 1 | 2002 | 246 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2010 | 5047 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2003 | 262 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 2290 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1212 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1875 | 0.010 |
Why?
|